オーガナイザー挨拶：山田 陽城1,2（1. DNDi Japan，2. 北里大） (3:45 PM - 3:50 PM)
Session information
Symposium
[S29] Recent progress in partnerships for NTD drug discovery in 2021
Sun. Mar 28, 2021 3:45 PM - 5:45 PM [Room F] Oral Presentation F (Online)
Organizer: Yamada Haruki, Nozaki Tomoyoshi (Grad. Sch. Med., Fac. Med., Univ. of Tokyo)
Neglected tropical diseases (NTDs), which expose about one-sixth of the world’s population to infection, are poorly marketable and existing drug development mechanisms do not work due to the high prevalence of patients in poorer areas of developing countries. DNDi is one of the not-for-profit international Product Development Partnership (PDP) based in Geneva established in 2003 to solve these problems and efficiently promoting research and development of NTDs drugs at all stages which meet the needs of endemic areas with industry-government-academia partners around the globe.
Academia and pharmaceutical companies are not doing anything. Original technologies and know-how that can be used to treat NTDs are constantly being created. However, academia has major hurdles to bring candidate compounds to the clinical phase, while most pharmaceutical companies no longer consider infectious diseases to be their main business area. Hence, PDP, which connects partners’ areas of expertise to manage projects and raise funds, provides a solution for NTDs drug discovery.
At this symposium, we will report the achievements and future development of the “NTD Drug Discovery Booster” that has been implemented with GHIT support since 2015, and the game-changing partnerships of industry-academia-government for new drug discovery and are happy to discuss the expected role of Japan in future drug discovery for NTDs.
3:50 PM - 4:08 PM
○Tatsuro Kuzuki1, Perry Benjamin1, Charles Mowbray1 (1. DNDi)
- PDF Download
-
Schedule
-
Like
4:08 PM - 4:26 PM
○Ryu Yoshida1, Rina Kaki1, Osamu Yoshida1, Takao Shishido1, Teruhisa Kato1, Yoshinori Yamano1 (1. SHIONOGI & Co., LTD.)
- PDF Download
-
Schedule
-
Like
4:26 PM - 4:44 PM
○Yuichiro Akao1, Atsuko Ochida1, Hiroya Muranishi1, Izumi Nomura1, Takashi Ichikawa1 (1. Takeda Pharmaceutical Company)
- PDF Download
-
Schedule
-
Like
4:44 PM - 5:02 PM
○Katsura Hata1 (1. Eisai)
- PDF Download
-
Schedule
-
Like
5:02 PM - 5:20 PM
○Ken Ishii1,2 (1. Institute of Medical Science U Tokyo, 2. Institute of Biomedical Innovation, Health and Nutrition)
- PDF Download
-
Schedule
-
Like
5:20 PM - 5:38 PM
○Fumiya Domoto1 (1. Astellas Pharma Inc.)
- PDF Download
-
Schedule
-
Like
質疑応答 (5:38 PM - 5:40 PM)
総括：野崎 智義（東大院医） (5:40 PM - 5:45 PM)